$Oscar Health, Inc.(OSCR)$ $Hims & Hers Health Inc.(HIMS)$ $Clover Health Corp(CLOV)$ ๐๐ฅ๐ $OSCR in the $16s: Back Where Smart Money Gets Involved ๐๐ฅ๐
I like this setup a lot. Itโs not breaking down, itโs coiling. The structure is tightening with precision.
Oscar Health just completed a textbook backtest of its monthly bias zone, holding the golden pocket near the 200-day and reclaiming the anchored VWAP from March. This is a strategic liquidity zone. More than 2.1 million shares exchanged hands during the flush, nearly twice its 10-day average, followed by stabilisation and controlled re-accumulation.
Technically, price is compressing between $16.32 and $16.69. RSI is resetting with bullish divergence emerging, and MACD is flattening at the zero line. If $16.69 breaks with conviction, Iโm eyeing a move to $18.65 and then a reclaim of the prior high at $23.57. That represents over 40% potential upside, with a measured move extension pointing to $25.50.
๐ก This is more than just a chart setup. Oscar is one of the few tech-enabled health insurers scaling efficiently. Membership growth is running at 41% year-on-year, while SG&A expense improved in Q1. The company is projecting 500%+ EPS growth this year and is on track for profitability ahead of sector peers.
From a valuation perspective, $OSCR remains deeply discounted. Based on forward EV/EBITDA and relative to its 2021 IPO benchmarks, the stock is currently undervalued by approximately 41%. With 20%+ revenue CAGR, expanding margins, and a moat in digital-first care delivery, Oscarโs model supports re-rating in both growth and value frameworks.
๐ง One underappreciated feature of this setup is the compression happening within a rising volume base. The current pattern reflects price acceptance, not rejection. Institutional players tend to build size under key resistance levels before directional pivots.
โ ๏ธ Key risk to monitor is the $15.80 zone. A clean break below that would negate the pattern and reopen downside gaps. As long as we hold above that level, the risk-reward remains highly favourable with upside targets clearly defined.
๐ What Iโm watching:
โข Clean breakout above $16.69 with volume confirmation
โข Q2 earnings catalysts including medical loss ratio guidance
โข Institutional flows and short interest adjustments
โข Sector sentiment across healthtech and managed care
Oscar isnโt just holding its ground, itโs building a base for something bigger.
๐ข Donโt miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets ๐๐ Iโm obsessed with hunting down the next big movers and sharing strategies that crush it. Letโs outsmart the market and stack those gains together! ๐
Trade like a boss! Happy trading ahead, Cheers, BC ๐๐๐๐๐
@Tiger_comments @TigerClub @TigerWire @TigerPicks @TigerStars @TigerObserver @Daily_Discussion
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
G8 bc ๐